-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) medication that is commonly used to treat depression, anxiety, and other mood disorders.
It is synthesized through a multi-step chemical process that involves several key reaction steps.
The synthesis of fluoxetine begins with the synthesis of the starting material for the reaction, which is the amino acid L-tyrosine.
This is done through a chemical reaction known as the a-amino acid oxidase method, which involves the oxidation of L-tyrosine using a chemical called para-amino-phenol and an oxidizing agent such as hydrogen peroxide.
Once the starting material has been synthesized, the next step in the synthesis of fluoxetine is the reaction of L-tyrosine with malonic acid to form a compound known as 4-iodo-L-tyrosine.
This is done through a reaction known as the iodination of L-tyrosine, which involves the addition of iodine to the molecule.
The next step in the synthesis of fluoxetine is the reaction of 4-iodo-L-tyrosine with a compound called 2-chloro-4-fluoro-N-methylphenetamine to form a compound known as 4-iodo-2-chloro-N-methylphenetamine.
This is done through a reaction known as the condensation reaction, which involves the addition of 4-iodo-L-tyrosine to 2-chloro-4-fluoro-N-methylphenetamine.
The next step in the synthesis of fluoxetine is the reaction of 4-iodo-2-chloro-N-methylphenetamine with a compound called 4-hydroxy-L-proline to form a compound known as 4-iodo-2-chloro-N-methyl-6-propylamino-tetralin.
This is done through a reaction known as the nitrylation reaction, which involves the addition of a nitro group (NO2) to the molecule.
The next step in the synthesis of fluoxetine is the reaction of 4-iodo-2-chloro-N-methyl-6-propylamino-tetralin with a compound called 2-fluoro-5-iodano-L-arabinose to form a compound known as 4-iodo-2-chloro-N-methyl-6-propylamino-tetralin-5-yl 2-fluoro-5-iodano-L-arabinoside.
This is done through a reaction known as the acylation reaction, which involves the addition of an acyl group (COCH3) to the molecule.
The final step in the synthesis of fluoxetine is the reaction of 4-iodo-2-chloro-N-methyl-6-propylamino-tetralin-5-yl 2-fluoro-5-iodano-L-arabinoside with a compound called phenylsiloxyacetic acid to form the final product, fluoxetine.
This is done through a reaction known as the deacylation reaction, which involves the removal of the acyl group from the molecule.
Once the synthesis of fluoxetine has been completed, the next step in the chemical industry is the purification and isolation of the final product.
This is typically done through a series of chemical reactions and techniques, such as crystallization and chromatography, which allow for the separation of fluoxetine from any impurities or contaminants that may have been present in the synthesis process.
After purification, the final product is typically converted into a pharmaceutical form, such as a tablet or a liquid, which can then be used to treat depression, anxiety, and other mood disorders.
The use of fluoxetine as a treatment for these conditions has been well-documented and has been shown to be effective in improving symptoms and helping patients to
